In summary, our study demonstrated for the first time that PGAM2 played important role in regulating pathological cardiac hypertrophy through interacting and modulating HSP90 stability and its downstream mTOR and IKKα / NFκB signaling. The gene discussed is NFKB1; the disease is cardiac hypertrophy.